A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis (Q58404248)
Jump to navigation
Jump to search
scientific article published on 01 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis |
scientific article published on 01 July 2005 |
Statements
A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis (English)
C Leonardi
B Conetta
R R Stoltz
P F Pierce
Ravuconazole onychomycosis group
1 reference
1 reference
1 reference